MEASuRE: Metreleptin Effectiveness And Safety Registry

Clinical trial NCT02325674 · RECRUITING

Trial details

NCT number: NCT02325674
Sponsor: Chiesi Farmaceutici S.p.A.
Status: RECRUITING
Study type: OBSERVATIONAL

Generalised Lipodystrophy Partial Lipodystrophy

Start date: 2016-10-11
Primary completion: 2031-10-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.